Full Event Guide

Screenshot 2022-01-14 090443

Agenda Highlights Include:

  • Examining the mechanisms underlying immune tolerance to drive antigen and epitope discovery with insights from the NIH, Vaccibody and Imcyse
  • Leveraging immune biomarkers and explore immune tolerance in diabetes with Novo Nordisk, COUR Pharmaceuticals and Diamyd Medical
  • Exploring the diversity of technologies and platforms for antigen delivery with Toleranzia, Allero Therapeutics, Idogen AB and AnTolRx Inc
  • Optimizing clinical durability and efficacy of antigen-specific immunotherapies with insights from WORG Pharmaceuticals and Cellerys